Advertisement
Advertisement

REVB

REVB logo

Revelation Biosciences, Inc. Common Stock

1.13
USD
Sponsored
-0.01
-0.88%
Aug 10, 15:59 UTC -4
Closed
exchange

After-Market

1.18

+0.05
+4.42%

Revelation Biosciences, Inc. Common Stock Profile

About

Revelation Biosciences Inc. is a clinical-stage life sciences company. It focused on the development of immunologic-based therapies for the prevention and treatment of disease. The company's product pipeline includes REVTx-99, REVTx-200 and REVDx-501. Revelation Biosciences Inc., formerly known as Petra Acquisition Inc., is based in NEW YORK.

Info & Links

CEO

James Rolke

Headquarters

4660 LAJOLLA VILLAGE DRIVE, SUITE 100
SAN DIEGO, CA 92122, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.revbiosciences.com

Auditor

Baker Tilly US, LLP

Share holders

30

Employees

9

Revelation Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

4.61M

Enterprise Value

-6.87M

Enterprise Value/EBITDA(ttm)

0.61

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.33

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-98.17%

Return on Invested Capital(ttm)

-101.85%

Return on Assets(ttm)

-81.68%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-11.24M

Net Income Available to Common(ttm)

-19.20M

Diluted EPS(ttm)

-12.31

Share Statistics

Beta (5Y Monthly)

-0.15

52-Week Change

-88.13%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

3.98M

Dividend Yield

0.00%

Float4

3.72M

% Held by Insiders

4.80%

% Held by Institutions

12.80%

Balance Sheet

Total Cash(mrq)

11.48M

Total Cash Per Share(mrq)

2.88

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.21%

Quick Ratio(mrq)

10.03%

Book Value Per Share(mrq)

2.58

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.51

Free Cash Flow(ytd)

-5.88M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement